Monthly Treatment Costs: Mounjaro vs Ozempic Comparison
Mounjaro Monthly Costs UK
Mounjaro's monthly cost depends on your prescribed dose. Starting doses (2.5mg) cost £129.99 for first-time buyers, then £144.99 monthly for returning customers with our £25 discount. Higher maintenance doses range from £174.99 (5mg returning customer price) to £293.99 (15mg returning customer price) monthly. This prescription-only treatment may help regulate appetite through dual GIP and GLP-1 hormone activation when used alongside reduced-calorie diet and increased physical activity.
Why Mounjaro May Offer Better Value
While Ozempic focuses on single GLP-1 activation, Mounjaro's dual hormone approach may provide enhanced appetite regulation for some patients. Our monthly pricing structure includes automatic discounts: £40 off your first order, then £25 off every subsequent order. This means your 5mg dose costs £159.99 initially, then just £174.99 monthly ongoing - significantly lower than typical Ozempic pricing elsewhere.
Budget-Friendly Bundle Options
Reduce monthly costs further with our bundle deals. The Intro Duo (2.5mg + 5mg pens) costs £299.99 for first orders - essentially £149.99 per month over two months. The Progress Trio provides three months' graduated dosing for £534.99 first order, working out at £178.33 monthly. These bundles help you budget treatment costs while following proper dose escalation.
Ongoing Monthly Investment Planning
Most patients stabilise on 7.5mg-15mg doses for maintenance. Budget £224.99-£293.99 monthly for returning customers at these therapeutic levels. Our automatic £25 discount applies to every order, and you'll receive reminders before your supply runs out. Clinical assessment is required for all orders, with 3 working days standard approval or 24-hour express upgrade available.
Order Your Monthly Supply Today
Start your Mounjaro treatment with £40 off your first order using code FIRST40. Choose single pens for monthly flexibility or bundles for better value. Complete our clinical assessment now - most patients receive approval within 3 working days and can begin treatment immediately upon delivery.
